Cargando…
How to Manage and Monitor Cardiac Dysfunction in Patients With Metastatic HER2-Positive Breast Cancer
[Figure: see text]
Autores principales: | Dent, Susan F., Moore, Heather, Raval, Priyanka, Alder, Laura, Guha, Avirup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537063/ https://www.ncbi.nlm.nih.gov/pubmed/36213363 http://dx.doi.org/10.1016/j.jaccao.2022.06.002 |
Ejemplares similares
-
Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: JACC: CardioOncology How To
por: Fradley, Michael G., et al.
Publicado: (2023) -
How to Follow, Manage and Treat Cardiac Dysfunction in Patients With Her2+ Breast Cancer
por: Blaes, Anne, et al.
Publicado: (2020) -
How to Treat Breast Cancer After Childhood Cancer: Management of Oncologic and Cardiovascular Concerns
por: Blaes, Anne H., et al.
Publicado: (2022) -
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
por: Dent, Susan F., et al.
Publicado: (2021) -
How to evaluate cardiac masses by cardiovascular magnetic resonance parametric mapping?
por: Bonnes, Judith, et al.
Publicado: (2023)